Evommune Inc (EVMN) Annual Balance Sheets

Annual · GAAP · USD millions
Access EVMN quarterly Balance Sheets →
From Evommune Inc through , shifts in Dec 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
Assets
Cash & cash equivalent44.06
Short-term Investments, Total105.14
Cash & Short-term Investments149.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current4.28
Total Current Assets153.48
Equipment/Property/Plant Net0.99
Long-term investments67.49
Other Assets, Noncurrent70.47
Operating Lease Right Of Use Asset1.47
Restricted Cash Noncurrent1.42
Total Assets224.95
Liabilities
Accounts Payable, Current AC7.76
Accrued Liabilities, Current AC9.55
Other Liabilities, Current0.61
Total Current Liabilities17.91
Total Long-term Debt0.00
Other liabilities, Noncurrent1.47
FinanceLeaseLiabilityNoncurrent0.18
Total Liabilities19.38
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock426.65
Retained Earnings / Accumulated Deficit-221.09
Other Equity0.00
Common Stockholder's Equity205.57
Total Stockholder's Equity205.57
Liabilities & Stockholder's Equity224.95
4 historic quarters locked

Sign in to unlock the full Evommune Inc balance sheet history.

About Evommune Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-093932

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License